Millipore Sigma Vibrant Logo

676380 Valproic Acid, Sodium Salt - CAS 1069-66-5 - Calbiochem

View This Product on Sigma-Aldrich
676380
価格&在庫状況を照会

概要

Replacement Information

主要スペック表

CAS #Empirical Formula
1069-66-5C₈H₁₅O₂Na

価格&在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
676380-5GMCN
在庫状況検索中…
現在国内在庫なし
現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      樹脂アンプル 5 gm
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示 
      値引
      ()
       
      弊社照会
      Description
      OverviewA cell-permeable, short-chained fatty acid that inhibits histone deacetylase (IC50 = 400 µM for HDAC1). Induces differentiation and inhibits proliferation of cell lines derived from human malignant gliomas. At therapeutic levels (0.35 mM - 1.04 mM), causes inositol depletion, inhibits both GSK-3α and -3β, activates ERK pathway and produces neurotropic effects. Has been used as an anti-epileptic agent. Also reported to stimulate peroxisome proliferator-activated receptor (PPAR) activity. Displays a potent teratogenic activity in humans and rodent models.
      Catalogue Number676380
      Brand Family Calbiochem®
      Synonyms2-Propylpentanoic Acid, Na
      References
      ReferencesGottlicher, M., et al. 2001. EMBO J. 20, 6969.
      Knupfer, M.M., et al. 2001. Anticancer Res. 21, 347.
      Phiel, C.J., et al. 2001. J. Biol. Chem. 276, 36734.
      Vaden, D.L., et al. 2001. J. Biol. Chem. 276, 15466.
      Yuan, P.X., et al. 2001. J. Biol. Chem. 276, 31674.
      Chen, G., et al. 1999. J. Neurochem. 72, 1327.
      Product Information
      CAS number1069-66-5
      ATP CompetitiveN
      FormWhite solid
      Hill FormulaC₈H₁₅O₂Na
      Chemical formulaC₈H₁₅O₂Na
      Hygroscopic Hygroscopic
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      ApplicationValproic Acid, Sodium Salt, CAS 1069-66-5, is a cell-permeable inhibitor of histone deacetylase (IC50 = 400 µM for HDAC1). Inhibits proliferation of human malignant glioma cell lines.
      Biological Information
      Primary TargetHDAC1
      Primary Target IC<sub>50</sub>400 µM
      Purity≥98% by GC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      RTECSYV7876000
      Safety Information
      R PhraseR: 20/21/22-36/37/38-61

      Harmful by inhalation, in contact with skin and if swallowed.
      Irritating to eyes, respiratory system and skin.
      May cause harm to the unborn child.
      S PhraseS: 3/7/9-22-36/37/39-45

      Keep container tightly closed, in a cool well ventilated place.
      Do not breathe dust.
      Wear suitable protective clothing, gloves and eye/face protection.
      In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible).
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Harmful & Carcinogenic / Teratogenic
      Storage +2°C to +8°C
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      676380-5GMCN 04055977183566

      Documentation

      Valproic Acid, Sodium Salt - CAS 1069-66-5 - Calbiochem (M)SDS

      タイトル

      英語版製品安全データシート((M)SDS) 

      Valproic Acid, Sodium Salt - CAS 1069-66-5 - Calbiochem 試験成績書(CoA)

      タイトルロット番号
      676380

      参考資料

      参考資料の概要
      Gottlicher, M., et al. 2001. EMBO J. 20, 6969.
      Knupfer, M.M., et al. 2001. Anticancer Res. 21, 347.
      Phiel, C.J., et al. 2001. J. Biol. Chem. 276, 36734.
      Vaden, D.L., et al. 2001. J. Biol. Chem. 276, 15466.
      Yuan, P.X., et al. 2001. J. Biol. Chem. 276, 31674.
      Chen, G., et al. 1999. J. Neurochem. 72, 1327.

      技術情報

      タイトル
      White Paper - The Message in the Marks: Deciphering Cancer Epigenetics

      データシート

      タイトル
      Reprogramming Cell Fate and Function Novel Strategies for iPSC Generation, Characterization, and Differentiation
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision27-April-2020 JSW
      Synonyms2-Propylpentanoic Acid, Na
      DescriptionA cell-permeable, short-chained fatty acid that inhibits histone deacetylase activity (IC50 = 400 µM for HDAC1). Induces differentiation and inhibits proliferation of cell lines derived from human malignant gliomas. At therapeutic levels (350 µM-1.04 mM), causes inositol depletion, inhibits both GSK-3α and -3β, activates the ERK pathway, and produces neurotropic effects. Has been used as an anti-epileptic agent. Also reported to stimulate peroxisome proliferator-activated receptor (PPAR) activity. Displays a potent teratogenic activity in humans and rodent models.
      FormWhite solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number1069-66-5
      RTECSYV7876000
      Chemical formulaC₈H₁₅O₂Na
      Structure formulaStructure formula
      Purity≥98% by GC
      SolubilityH₂O (50 mg/ml)
      Storage +2°C to +8°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Harmful & Carcinogenic / Teratogenic
      Merck USA index14, 9913
      ReferencesGottlicher, M., et al. 2001. EMBO J. 20, 6969.
      Knupfer, M.M., et al. 2001. Anticancer Res. 21, 347.
      Phiel, C.J., et al. 2001. J. Biol. Chem. 276, 36734.
      Vaden, D.L., et al. 2001. J. Biol. Chem. 276, 15466.
      Yuan, P.X., et al. 2001. J. Biol. Chem. 276, 31674.
      Chen, G., et al. 1999. J. Neurochem. 72, 1327.